BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34852932)

  • 1. Mitochondrial dysfunction as a trigger of programmed axon death.
    Merlini E; Coleman MP; Loreto A
    Trends Neurosci; 2022 Jan; 45(1):53-63. PubMed ID: 34852932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed axon degeneration: from mouse to mechanism to medicine.
    Coleman MP; Höke A
    Nat Rev Neurosci; 2020 Apr; 21(4):183-196. PubMed ID: 32152523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.
    Summers DW; DiAntonio A; Milbrandt J
    J Neurosci; 2014 Jul; 34(28):9338-50. PubMed ID: 25009267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria.
    Ding C; Wu Y; Dabas H; Hammarlund M
    Elife; 2022 Mar; 11():. PubMed ID: 35285800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
    Conforti L; Gilley J; Coleman MP
    Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Pebbled/RREB1 regulates injury-induced axon degeneration.
    Farley JE; Burdett TC; Barria R; Neukomm LJ; Kenna KP; Landers JE; Freeman MR
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1358-1363. PubMed ID: 29295933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Localization of SARM1 in Acrylamide Intoxication Induces Mitophagy and Limits Neuropathy.
    Wang S; Song M; Yong H; Zhang C; Kang K; Liu Z; Yang Y; Huang Z; Wang S; Ge H; Zhao X; Song F
    Mol Neurobiol; 2022 Dec; 59(12):7337-7353. PubMed ID: 36171479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARM1 axon degeneration pathway: control of the NAD
    Figley MD; DiAntonio A
    Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
    Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
    Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARM1-mediated wallerian degeneration: A possible mechanism underlying organophosphorus-induced delayed neuropathy.
    Song M; Kang K; Song F
    Med Hypotheses; 2021 Oct; 155():110666. PubMed ID: 34455132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy.
    DiAntonio A
    Pain; 2019 May; 160 Suppl 1(Suppl 1):S17-S22. PubMed ID: 31008845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitotoxicity upregulates SARM1 protein expression and promotes Wallerian-like degeneration of retinal ganglion cells and their axons.
    Massoll C; Mando W; Chintala SK
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2771-80. PubMed ID: 23518770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARM1 can be a potential therapeutic target for spinal cord injury.
    Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
    Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
    Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
    Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases.
    Arthur-Farraj P; Coleman MP
    Neurotherapeutics; 2021 Oct; 18(4):2200-2221. PubMed ID: 34595734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated mitochondrial quality control, the heel of Achilles in elucidating the role of autophagy in SARM1-mediated axon degeneration.
    Wang S; Zhang Y; Song M; Zhao X; Song F
    J Neurosci Res; 2024 Jan; 102(1):e25292. PubMed ID: 38284842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.